QA: Rezolute Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2018_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509261')"}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 4,928,553
1 IntangibleAssetsNetIncludingGoodwill 44,322
2 PropertyPlantAndEquipmentNet 5,325,401
3 remainder_Assets 330,634
4 LiabilitiesCurrent 1,771,322
5 LiabilitiesNoncurrent 329,621
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,229,314
9 ResearchAndDevelopmentExpense 12,094,734
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 46,916
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,628,910
1 Liabilities 2,100,943
2 Expenses 20,324,048
3 Revenues 0
4 StockholdersEquity 8,527,967
5 NetIncome -20,277,132
6 ComprehensiveNetIncome -20,277,132
7 BaseVar 16,550,408
8 EconomicCapitalRatio -0.881

Edgar->Model Mapping

Feature Distribution

Change over Time